FSTX

F-star Therapeutics, Inc. Common Stock

Delisted

FSTX was delisted on the 8th of March, 2023.

53 hedge funds and large institutions have $45.1M invested in F-star Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+13
Holders Change %
+32.5%
% of All Funds
0.9%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
21
Increased
11
Reduced
10
Closed
8
Calls
$272K
Puts
$1.84M
Net Calls
-$1.57M
Net Calls Change
-$1.63M
Name Holding Trade Value Shares
Change
Shares
Change %
CC
51
Cannell Capital
Wyoming
$11K +$11K +1,804 New
JPMorgan Chase & Co
52
JPMorgan Chase & Co
New York
$9K -$119K -19,837 -93%
TWA
53
TCI Wealth Advisors
Arizona
$2K
Adage Capital Partners
54
Adage Capital Partners
Massachusetts
-$3.2M -900,000 Closed
AFM
55
Anson Funds Management
Texas
-$658K -185,261 Closed
Millennium Management
56
Millennium Management
New York
-$305K -85,834 Closed
D.E. Shaw & Co
57
D.E. Shaw & Co
New York
-$56K -15,865 Closed
Marshall Wace
58
Marshall Wace
United Kingdom
-$37K -10,456 Closed
TRCT
59
Tower Research Capital (TRC)
New York
-$11K -3,065 Closed
Bank of America
60
Bank of America
North Carolina
-$1K -162 Closed